STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma
NCT ID: NCT05280366
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
150 participants
INTERVENTIONAL
2022-02-09
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
NCT06230393
A First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the STREAMLINE SURGICAL SYSTEM in Patients With Open-Angle Glaucoma
NCT05089474
A FIH Trial of the STREAMLINE™ SURGICAL SYSTEM
NCT04700189
A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.
NCT00326014
A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.
NCT00326066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Streamline Surgical System
Streamline Surgical System procedure administered
Streamline Surgical System
Completion of the Streamline Surgical System procedure
iStent Inject W
iStent Inject W implanted
iStent Inject W
Implantation of competitor device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Streamline Surgical System
Completion of the Streamline Surgical System procedure
iStent Inject W
Implantation of competitor device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New World Medical, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elysia Ison, OD
Role: STUDY_DIRECTOR
New World Medical, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vold Vision
Fayetteville, Arkansas, United States
Visionary Research Institute
Newport Beach, California, United States
Wolstan and Goldberg Eye Associates
Torrance, California, United States
University of Colorado
Aurora, Colorado, United States
Ocala Eye
Ocala, Florida, United States
Georgia Eye Partners
Atlanta, Georgia, United States
The Eye Institute
Louisville, Kentucky, United States
Ophthalmology Associates
St Louis, Missouri, United States
Eye Associates of North New Jersey
Dover, New Jersey, United States
Eye Associates Surgical Center
Vineland, New Jersey, United States
Ross Eye Institute
Orchard Park, New York, United States
Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
University Eye Specialists
Maryville, Tennessee, United States
Ophthalmology Associates
Fort Worth, Texas, United States
Berkely Eye Center
Houston, Texas, United States
R & R Eye Research
San Antonio, Texas, United States
Piedmont Eye Center
Lynchburg, Virginia, United States
Eye Centers of Racine and Kenosha
Racine, Wisconsin, United States
Clinica 20/20
San José, , Costa Rica
Clinica Laser y Ultrasonido Ocular
Puebla City, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DF6-CL-21-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.